Stock GNPX GENPREX, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Genprex, Inc.

Equities

GNPX

US3724462037

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-05-23 EDT 		5-day change 1st Jan Change
2.21 USD -6.75% Intraday chart for Genprex, Inc. -11.78% -75.98%
05-14 Genprex Doses First Patient in Acclaim-3 Clinical Study of Reqorsa Immunogene Therapy in Combination with Tecentriq to Treat Small Cell Lung Cancer CI
05-09 Genprex, Inc Announces Executive Changes CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
GENPREX, INC. Stock Genprex, Inc.
 4.97M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 115B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 106B
BIONTECH SE Stock BioNTech SE
 24.69B -
ARGENX SE Stock argenx SE
 21.97B -
GENMAB A/S Stock Genmab A/S
 19.27B
  1. Stock Market
  2. Equities
  3. GNPX Stock
  4. Charts Genprex, Inc.
  5. Sector Chart